Exosens (Ticker: Pending) is an optical component company providing night vision tools and photo sensor technology for defense, medical, and nuclear scientific applications. Exosens will list on June 7, 2024, on Euronext Paris. The firm is selling shares at the price of 20 euros per share, valuing the company at approximately 1 billion euros (USD 1.08 billion). The total offer size, including the greenshoe option, has been upsized to 20 million shares, raising 400 million euros (USD 433.78 million).

The IPO is managed through a private placement with institutional investors and a reserved capital increase for the state-owned investment bank Bpifrance. Exosens will remain controlled by private equity firm Groupe HLD after the IPO. The book-building process saw significant demand, with the books multiple times covered, leading to an accelerated closing and strong investor interest. Allocations and the first day of trading are expected on June 7, 2024.